Drug class
Methylxanthine bronchodilator; theophylline derivative
Mechanism of action
Produces bronchodilation through methylxanthine pharmacology, including phosphodiesterase inhibition and adenosine-receptor antagonism, increasing intracellular cyclic AMP in bronchial smooth muscle. Clinical effect and adverse effects depend on systemic exposure.
General use cases
- Historically used for symptomatic treatment of asthma and bronchospasm in countries where diprophylline products remain authorised; current role is limited by availability and the narrow therapeutic margin of methylxanthines
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
